Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Sales | 10,981 | 20,100 | 14,528 | 19,378 | 11,195 |
| Gross Profit | 10,981 | 20,100 | 14,528 | 19,378 | 11,195 |
| Operating Expenses | 24,472 | 23,245 | 23,268 | 25,018 | 24,964 |
| Operating Income | -13,491 | -3,145 | -8,740 | -5,640 | -13,769 |
| Other Income | 1,126 | 1,151 | 1,103 | 966 | 741 |
| Pre-tax Income | -12,365 | -1,994 | -7,637 | -4,674 | -13,028 |
| Income Tax | 12 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -12,377 | -2,040 | -7,637 | -4,674 | -13,028 |
| Net Income | $-12,377 | $-2,040 | $-7,637 | $-4,674 | $-13,028 |
| EPS Basic Total Ops | -0.38 | -0.07 | -0.23 | -0.14 | -0.40 |
| EPS Basic Continuous Ops | -0.38 | -0.06 | -0.23 | -0.14 | -0.40 |
| EPS Diluted Total Ops | -0.38 | -0.07 | -0.23 | -0.14 | -0.40 |
| EPS Diluted Continuous Ops | -0.38 | -0.06 | -0.23 | -0.14 | -0.40 |
| EBITDA(a) | $-13,005 | $-2,679 | $-8,252 | $-4,986 | $-12,653 |